Corporate Overview

diaDexus develops and commercializes proprietary diagnostic products addressing unmet needs in cardiovascular disease (CVD).

Learn More - Corporate Overview


PLAC Test LogoThe PLAC® Test for Lp-PLA2 is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease (CHD) and ischemic stroke associated with atherosclerosis.

The PLAC® Test for Lp-PLA2 Activity is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events.

To learn more about PLAC tests, visit

Learn More - Products

Events & Presentations

View More Recent News

Recent News

View More Recent News

©2014 diaDexus, Inc. | DIADEXUS and PLAC are U.S. Registered Trademarks of diaDexus, Inc.